20/20 BioResponse's BioCheck® Kit for Screening Suspicious Powders Receives SAFETY Act Designation from DHS
ROCKVILLE, Md.--(BUSINESS WIRE)--The BioCheck® Powdered Screening Test Kit, a product of 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. has earned designation as a Qualified Anti-Terrorism Technology under the U.S. Department of Homeland Security (DHS)’s SAFETY Act .